Medivation lines up cancer drug deal — with an escape
October 24, 2014 at 16:48 PM EDT
Medivation Inc. broadened its cancer drug portfolio in a low-risk deal with a $5 million upfront payment and an escape hatch...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.